ICASA 2015 1 |1 | LEARNING FROM “B+” IMPLICATIONS FOR IMPLEMENTING “TREAT ALL” Dr. Gottfried Hirnschall WHO, Geneva ICASA Harare, December 2015.

Slides:



Advertisements
Similar presentations
TB/HIV Research Priorities: TB Preventive Therapy.
Advertisements

The 2013 Consolidated WHO Guidelines on ARV Use: Implementing to Achieve Maximum Impact Gottfried Hirnschall, MD, MPH Director, HIV/AIDS Department, WHO.
Excellent healthcare – locally delivered Strengthening the treatment cascade Evidence and practice Dr Nathan Ford Treatment and Care Department of HIV.
Recommendations of BU/HIV expert panel influenced by results from Akonolinga All BU patients should be offered quality provider-initiated HIV testing and.
Dr Tin Tin Sint Department of HIV/AIDS World Health Organization
HIV/AIDS DEPARTMENT WHO Rachel Baggaley Reuben Granich Amitabh Suthar Marco Antonio De Avila Vitoria Eyerusalem Negussie Kathleen Fox Ying-Ru Lo Andrew.
WHO Guidelines for treatment monitoring Nathan Ford Dept of HIV/AIDS World Health Organization.
CD4 assessment among newly diagnosed HIV-infected pregnant women in India’s National Prevention of Parent to Child Transmission Programme (PPTCT) Implications.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Implications for Countries: Critical Issues in Service Delivery and Decision Making Dr. Yogan Pillay Deputy.
The President’s Emergency Plan for AIDS Relief Next Generation Indicators.
HIV/AIDS DEPARTMENT Rachel Baggaley Eyerusalem Negussie Andrew Ball.
Translating the Vision Towards Universal Access Dr Zengani Chirwa.
Integrated Health Programs for Women and Children: Lessons from the Field Dr. Ambrose Misore Project Director, APHIA II Western, PATH’s Kenya Country Program.
Joan Holloway Vice President, Global Health Initiatives Multidisciplinary Care Team Delivery of Integrated HIV Services.
Enabling Continuity of a Public Health ARV Treatment program in a resource limited setting: The Case of the transition of the African Comprehensive HIV/AIDS.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
Integrating ART/PMTCT services into MNCH services to enhance test & treat strategy for HIV infected pregnant and lactating women (Option B+) WHO Satellite.
World Health Organization. Task shifting for integrated and decentralized HIV treatment Eyerusalem Negussie, Margaret Streeten, Brian Pazvakavambwa, Amitabh.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
1 |1 | World Health Organization Western Pacific Region Regional Progress on Prevention of Mother-to-Child Transmission of HIV and Syphilis Ying-Ru Lo,
1 |1 | Treatment 2.0 Catalyzing the Next Phase of Scale-up Decentralized, Integrated and Community-Centred Service Delivery.
PMTCT - The Platform for integrating HIV/AIDS Services in the MCH Clinic. Bola Oyeledun, MD, MPH Track 1.0 Partners Meeting Washington DC. August 2008.
Fast-Tracking Treatment to End AIDS ICASA Ambassador Deborah Birx, MD U.S. Global AIDS Coordinator November 30, 2015.
PRACTICAL STEPS TO IMPLEMENTATION OF SRH AND HIV LINKAGES The Role of Government The Kingdom of Swaziland Experience Presented by Rejoice Nkambule Deputy.
INVESTING IN COMMUNITY SYSTEMS TO SUPPORT LIFELONG ART INITIATED IN MATERNAL & CHILD HEALTH SETTINGS Dr. Chewe Luo MD, PhD, FRCP UNICEF PROGRAM DIVISION.
Do Adolescents Equally Utilize PMTCT Services as Adult Women? Data from Patient Tracking Database in Zimbabwe 18 th ICASA, Harare 3 December 2015 Reuben.
Task shifting and sharing for distributing antiretroviral medications to patients living with HIV: Systematic review and meta-analysis Wiysonge, Charles.
CQUIN: The HIV Coverage, Quality, and Impact Network Miriam Rabkin, MD, MPH Director for Health Systems Strategies ICAP Columbia University.
The 2013 treatment guidelines and key implementation challenges Martina Penazzato IATT Normative Guidance Advisor HIV Department, WHO (Geneva, Switzerland)
Excellent healthcare – locally delivered WHO Test & treat evidence and policy mapping What will it take to make the Test and Start guidelines a reality?'
#IAS2017 Increasing HIV test uptake & case finding through assisted HIV partner notification 25 July, 2017 Shona Dalal Department of.
Approach to guideline development
Lynne Wilkinson IAS.
Dr. Tsitsi Apollo Ministry of Health and Child Care, Zimbabwe
Differentiated Monitoring & Evaluation
How differentiated care supports “Tx all” and Dr
Contents Global impact 2.Service cascade 3. Policies and WHO support.
The CQUIN Learning Network: Partnering to Advance Differentiated Care
Differentiated service delivery: Youth perspectives
World Health Organization
Differentiated Service Delivery: Innovating for Impact
COMDIS-HSD Addressing national government priorities
“Treatment for all pregnant women:
New Directions in the future 2015 Consolidated ARV Guidelines Update Meg Doherty, MD, PhD, MPH 19 July 2015 WHO Satellite Vancouver – IAS 2015.
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
Using HIV cohort collaboration data to evaluate and inform policy and practice Mary-Ann Davies.
Richard hayes London school of hygiene & Tropical Medicine
HIV-associated TB mortality and blocks in the cascade
Closing the Treatment Gap of Children Living with HIV
WHO, UNICEF, UNFPA, UNESCO & GNP+
New Prevention: From DREAMS to Reality
National Department of Health: South Africa
The use of cotrimoxazole prophylaxis in the context of HIV infection
Global updates on elimination and the concept of pre-elimination Shaffiq Essajee WHO HIV Department IATT Webinar: March 17th 2016.
World Health Organization
What Will It Take To End Pediatric AIDS
Country Experiences monitoring new ARVs: Introductory Remarks
The role of CD4 in patient monitoring Amsterdam July 2018
Advanced HIV: a WHO perspective
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Mapping the Scale-Up of DSD: A 13-Country Health Facility Survey
WHO 2015 GUIDELINES AND FAST TRACKING TOWARDS : Regional perspective
National Department of Health: South Africa
ANTIRETROVIRAL TREATMENT IN RESOURCE-LIMITED SETTINGS: PROGRESS & CHALLENGES IN SOUTH AFRICA YOGAN PILLAY DEPARTMENT OF HEALTH, SOUTH AFRICA IAS, 2014.
Contents Global impact 2.Service cascade 3. Policies and WHO support.
CQUIN Call to Action Peter Preko MB, ChB Project Director, CQUIN
Jessica Justman, MD Senior Technical Director ICAP at Columbia
Target-Setting, Impact and Resource Needs
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

ICASA |1 | LEARNING FROM “B+” IMPLICATIONS FOR IMPLEMENTING “TREAT ALL” Dr. Gottfried Hirnschall WHO, Geneva ICASA Harare, December 2015

“Option B+” has been one of the most widely adopted of all WHO recommendations B+ policy adopted in 80% of 144 LMIC surveyed Among the countries of the Global Plan, B+ has been implemented in over 90%

ART should be initiated among all adults with HIV regardless of WHO clinical stage and at any CD4 cell count strong recommendation, moderate-quality evidence As a priority, ART should be initiated among all adults with severe or advanced HIV clinical disease (WHO clinical stage 3 or 4) and adults with CD4 count ≤350 cells/mm 3 strong recommendation, moderate-quality evidence For the first time in the history of ARV guidelines… –we will see ONE recommendation for everyone –We will erase the distinction between pregnant women and everybody else that has long contributed to poor ART access for women who happen to be pregnant WHO 2015 ARV guidelines recommend “TREAT ALL”

Lessons from B+ to implement “Treat All” B+ has created a paradigm shift in service delivery –in many countries all MCH clinics are now providing ART –HOW CAN WE LEARN FROM THIS AND USE THE B+ APPROACH TO DELIVER DECENTRALIZED UNIVERSAL ART TO ALL? Many B+ programs initiate ART on the same day as HIV is diagnosed –WHAT DOES B+ TELL US ABOUT SAME-DAY ART START AND WHAT IT MEANS FOR PROGRAMS CONSIDERING UNIVERSAL ART FOR ALL Retention especially post partum retention has been a challenge for many B+ programs –WHAT LEARNING IS THERE FROM B+ ON HOW THIS CAN WORK IN PRACTICE?

Programmes should provide community support for people living with HIV to improve retention in HIV care. Interventions:  Multi-faceted, community-based lay CHWs/ “patient advocates” providing adherence, treatment and psychosocial support.  Adherence clubs and peer groups providing patient support: postpartum and breastfeeding women, children, key population, adolescents, men. The importance of community support is highlighted in new recommendations for retention

As a result of B+, maternal coverage in the 21 Global Plan countries now exceeds adults & children Percentage of pregnant women, adults and children (0-14 years) receiving ART in the 21 Global Plan priority countries from Source: Courtesy of Karusa Kiragu, UNAIDS

2015 WHO ARV Consolidated Guidelines

Acknowledgements Core Group Co-Chairs Wafaa El-Sadr (ICAP and Columbia University) Yogan Pillay (SA MoH) SD Guideline Development Group Co-Chairs Anthony Harries (the Union) Fabio Mesquita (Brazil MOH) Members of service delivery GDG Special thanks to all the external experts who contributed as members of the Guideline Development Groups, and to those who contributed to the GRADE systematic reviews and supporting evidence which informed the guidelines process. WHO Department Meg Doherty Andrew Ball Rachel Baggaley Rachel Beanland Marco Vitoria Martina Penazzato Shaffiq Essajee Nathan Ford Eyerusalem Kebede Negussie Joseph Perriëns Francoise Renaud Bob Grant (consultant) Annabel Baddaley Haileyesus Getahun Other Contributors The University of California, San Francisco & University of Basel Global Evaluation Service (GES) The HIV Modelling Consortium JHU Pangaea APN+, AHF, ITPC, EATG, AFROCAB, IeDEA Collaboration The Global Network of People living with HIV/AIDS Avenir Health CDC PEPFAR Bill and Melinda Gates Foundation UNICEF, UNAIDS, GF